Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics Revenue

Fulcrum Therapeutics had revenue of $80.00M in the twelve months ending March 31, 2025, up 3,087.25% year-over-year. In the year 2024, Fulcrum Therapeutics had annual revenue of $80.00M with 2,752.05% growth.

• Revenue (ttm): $80.00M
• Revenue Growth: +3,087.25%
• P/S Ratio: 5.31
• Revenue / Employee: $1,777,778
• Employees: 45
• Market Cap: 367.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	80.00M	77.20M	2,752.05%
Dec 31, 2023	2.81M	-3.54M	-55.77%
Dec 31, 2022	6.34M	-12.82M	-66.90%
Dec 31, 2021	19.16M	10.34M	117.19%
Dec 31, 2020	8.82M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.